2024-03-29T07:43:36Zhttps://www.tdx.cat/oai/requestoai:www.tdx.cat:10803/2831332017-09-03T20:25:30Zcom_10803_1col_10803_131463
nam a 5i 4500
Malaltia d'Alzheimer
Enfermedad de Alzheimer
Alzheimer's disease
Oligòmers
Oligómeros (Polímeros)
Oligomers
Agregació (Química)
Agregación (Química)
Aggregation (Chemistry)
Beta-amiloide
Amyloid-beta
Study of the aggregation process of the amyloid beta-protein associated to Alzheimer's disease. Examination of pharmaceutically important small molecules.
[Barcelona] :
Universitat de Barcelona,
2014
Accés lliure
http://hdl.handle.net/10803/283133
cr |||||||||||
AAMMDDs2014 sp ||||fsm||||0|| 0 eng|c
Serra Vidal, Bernat,
autor
1 recurs en línia (108 pàgines)
Tesi realitzada a l'Institut de Recerca Biomèdica de Barcelona (IRBB)
Tesi
Doctorat
Universitat de Barcelona. Facultat de Química
2014
Universitat de Barcelona. Facultat de Química
Tesis i dissertacions electròniques
Giralt Lledó, Ernest,
supervisor acadèmic
Carulla Casanovas, Natàlia,
supervisor acadèmic
TDX
Alzheimer’s disease (AD) is a neurodegenerative disorder which major risk factor is age. Current drugs only offer symptomatic alleviation in AD, thus a disease-modifying treatment is urgent. The amyloid-β (Aβ) protein aggregation is strongly associated with AD. Aggregates of Aβ are deposited in the form of amyloid plaques in the brains of AD patients. Aβ monomer self-assembles into intermediate oligomeric species that evolve into protofibrils, that finally aggregate into amyloid fibrils, the main component of amyloid plaques. The soluble Aβ oligomers have been posed as the main causative agents of the neurotoxicity and cognitive decline observed in AD. However, the heterogeneity of the aggregation process together with the dynamic and transient nature of Aβ oligomers, makes it very diffcult to characterize each of the aggregates formed and thus to establish the specific features that make them responsible for the neurotoxicity observed.
Pulse-labelling hydrogen deuterium exchange experiments analyzed by electrospray mass spectrometry (PL-HDX-ESI-MS) allow the detection, characterization, and quantification of the species formed during aggregation on the basis of structural differences among them. We applied this strategy to study the aggregation of three Aβ variants: Aβ40, the peptide most abundantly produced, Aβ42, the variant most linked to neurotoxicity in AD, and the muta¬tion E22Δ-Aβ42, a peptide that was first described to form oligomers but not amyloid fibrils although later reports showed that it indeed formed amyloid fibrils. The application of this strategy allowed detection of three species for Aβ40 and Aβ42: Early aggregates (EA), Protofibrils (PF) and Fibrils (F). In the case of E22Δ-Aβ42 we detected two species, PFE22Δ-Aβ42 and FE22Δ-Aβ42. These experiments imply that different species populate Aβ aggregation and that important structural rearrangements occur during this process. Having been able to “dissect” the different species populating Aβ aggregation, we then aimed at assigning the contribution of each species to neurotoxicity. To this end, in parallel experiments we assessed cell viability by means of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay in primary neural cultures. We found that protofibrillar species were the aggregates that most correlated with the neurotoxicity observed.
b
ES-BaCBU
cat
rda
ES-BaCBU
text
txt
rdacontent
informàtic
c
rdamedia
recurs en línia
cr
rdacarrier